Total Payments
$4,728
2024 Payments
$13.29
Companies
16
Transactions
133
Medicare Patients
1,014
Medicare Billing
$168,294
Payment Breakdown by Category
Consulting$2,770 (58.6%)
Food & Beverage$1,958 (41.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,770 | 1 | 58.6% |
| Food and Beverage | $1,958 | 132 | 41.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $2,782 | 2 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $635.50 | 43 | $0 (2020) |
| Lundbeck LLC | $282.88 | 18 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $278.07 | 16 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $184.02 | 19 | $0 (2019) |
| ABBVIE INC. | $135.91 | 6 | $0 (2023) |
| Allergan Inc. | $109.42 | 8 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $92.35 | 5 | $0 (2020) |
| Alkermes, Inc. | $66.40 | 4 | $0 (2018) |
| Supernus Pharmaceuticals, Inc. | $65.11 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.29 | 1 | E.R. Squibb & Sons, L.L.C. ($13.29) |
| 2023 | $180.52 | 9 | ABBVIE INC. ($93.63) |
| 2022 | $80.05 | 5 | ABBVIE INC. ($42.28) |
| 2020 | $82.37 | 4 | Lundbeck LLC ($23.10) |
| 2019 | $284.87 | 23 | Otsuka America Pharmaceutical, Inc. ($80.02) |
| 2018 | $656.68 | 42 | Otsuka America Pharmaceutical, Inc. ($308.03) |
| 2017 | $3,431 | 49 | Indivior Inc. ($2,770) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.29 | General |
| Category: Psychiatry/Psychology | ||||||
| 07/11/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Neuroscience | ||||||
| 05/30/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Neuroscience | ||||||
| 05/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.50 | General |
| Category: PSYCHOLOGY | ||||||
| 05/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: INSOMNIA | ||||||
| 01/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2023 | Supernus Pharmaceuticals, Inc. | OSMOLEX ER (Drug) | Food and Beverage | Cash or cash equivalent | $12.84 | General |
| Category: PSYCHOLOGY | ||||||
| 11/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2022 | Supernus Pharmaceuticals, Inc. | OSMOLEX ER (Drug) | Food and Beverage | Cash or cash equivalent | $12.42 | General |
| Category: PSYCHOLOGY | ||||||
| 09/19/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2022 | Supernus Pharmaceuticals, Inc. | OSMOLEX ER (Drug) | Food and Beverage | Cash or cash equivalent | $13.62 | General |
| Category: PSYCHOLOGY | ||||||
| 08/15/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $11.73 | General |
| Category: PSYCHOLOGY | ||||||
| 02/19/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Neuroscience | ||||||
| 02/13/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: PSYCHIATRY | ||||||
| 01/23/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2020 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: CNS | ||||||
| 12/06/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: CNS | ||||||
| 10/10/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Central Nervous System (CNS) | ||||||
| 10/09/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 157 | 608 | $84,140 | $42,582 |
| 2022 | 1 | 181 | 644 | $150,385 | $43,765 |
| 2021 | 5 | 281 | 818 | $196,790 | $51,210 |
| 2020 | 5 | 395 | 691 | $158,956 | $30,737 |
Total Patients
1,014
Total Services
2,761
Medicare Billing
$168,294
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 589 | $82,181 | $41,712 | 50.8% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 13 | 19 | $1,959 | $870.16 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 181 | 644 | $150,385 | $43,765 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 209 | 678 | $169,500 | $42,964 | 25.3% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 12 | 45 | $7,650 | $2,783 | 36.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 18 | 18 | $4,500 | $2,077 | 46.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 44 | $11,000 | $1,751 | 15.9% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 14 | 33 | $4,139 | $1,635 | 39.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 201 | 386 | $94,425 | $18,391 | 19.5% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 30 | 104 | $17,985 | $6,568 | 36.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 137 | 160 | $39,900 | $3,009 | 7.5% |
| 90832 | Psychotherapy, 30 minutes | Office | 2020 | 15 | 29 | $3,646 | $1,411 | 38.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 12 | 12 | $3,000 | $1,359 | 45.3% |
About Dr. Jane Maxwell, M.D
Dr. Jane Maxwell, M.D is a Psychiatry healthcare provider based in Saranac Lake, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467463703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jane Maxwell, M.D has received a total of $4,728 in payments from pharmaceutical and medical device companies, with $13.29 received in 2024. These payments were reported across 133 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($2,770).
As a Medicare-enrolled provider, Maxwell has provided services to 1,014 Medicare beneficiaries, totaling 2,761 services with total Medicare billing of $168,294. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Saranac Lake, NY
- Active Since 08/11/2006
- Last Updated 05/19/2009
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467463703
Products in Payments
- SUBOXONE SUBLINGUAL FILM (Drug) $2,770
- REXULTI (Drug) $521.39
- ABILIFY MAINTENA (Drug) $339.51
- VRAYLAR (Drug) $245.33
- LATUDA (Drug) $184.02
- INVEGA SUSTENNA (Drug) $182.70
- TRINTELLIX (Drug) $80.08
- SPRAVATO (Drug) $77.82
- Trintellix (Drug) $69.75
- Aristada 441 mg (Drug) $66.40
- OSMOLEX ER (Drug) $38.88
- AUSTEDO (Drug) $29.07
- QELBREE (Drug) $26.23
- INVEGA TRINZA (Drug) $17.55
- QUVIVIQ (Drug) $14.55
- INGREZZA (Drug) $14.24
- NUEDEXTA (Drug) $13.46
- COBENFY (Drug) $13.29
- SUBLOCADE (Drug) $11.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.